Sorry, you do not have access to this eBook
A subscription is required to access the full text content of this book.
The conventional view on gene doping is that it should be treated like other forms of doping, both in scientific and ethical terms, as evidenced by its inclusion within the World Anti-Doping Code back in 2003 (World Anti-Doping Agency (WADA), 2003). The basis for this position is that, like other forms of doping, gene doping involves the use of medical technologies for nontherapeutic biological modifications, as described in WADA’s initial terminology banning gene doping, which described it as:
M3: Gene Doping The non-therapeutic use of cells, genes, genetic elements, or the modulation of gene expression, having the capacity to enhance athlete performance.
A subscription is required to access the full text content of this book.
Other ways to access this content: